MediFind
Condition

Bronchopulmonary Dysplasia

Symptoms, Doctors, Treatments, Research & More

Latest Research

Latest Advance
Study
  • Condition: Bronchopulmonary Dysplasia (BPD)
  • Journal: Journal of translational medicine
  • Treatment Used: Human Umbilical Cord-derived Mesenchymal Stem/Stromal Cells (UC-MSC)
  • Number of Patients: 4
  • Published —
This study reported the safety of the allogeneic umbilical cord-derived mesenchymal stem/stromal cells (allo-UC-MSCs) in infants with bronchopulmonary dysplasia (BPD).
Latest Advance
Study
  • Condition: Extremely Low-Birth-Weight in Infants
  • Journal: JAMA
  • Treatment Used: Liberal versus Restrictive Transfusion Thresholds
  • Number of Patients: 1013
  • Published —
In this study, researchers compared the outcomes of using liberal versus restrictive red blood cell transfusion strategies for infants born with extremely low birth weight.
Latest Advance
Study
  • Condition: Adolescents Born Very Prematurely
  • Journal: PloS one
  • Treatment Used: Postnatal Dexamethasone
  • Number of Patients: 159
  • Published —
This study assessed if lung function with increasing age differed between adolescents who had been born very prematurely and who had and had not received postnatal corticosteroids.
Latest Advance
Study
  • Condition: Inadequate Breathing at Birth
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Sustained Versus Standard Inflations
  • Number of Patients: 1467
  • Published —
In this study, researchers compared the effectiveness of sustained versus standard inflations during neonatal resuscitation due to inadequate breathing at birth.
Latest Advance
Study
  • Condition: Bronchopulmonary Dysplasia (BPD)
  • Journal: Nutrients
  • Treatment Used: Postnatal Systemic Steroids
  • Number of Patients: 17621
  • Published —
This study evaluated the safety and effectiveness of postnatal steroids for the treatment of preterm infants with bronchopulmonary dysplasia (BPD).
Latest Advance
Study
  • Condition: Bronchopulmonary Dysplasia (BPD)
  • Journal: Pediatrics international : official journal of the Japan Pediatric Society
  • Treatment Used: Mesenchymal Stem Cells (MSCs)
  • Number of Patients: 0
  • Published —
This article discusses mesenchymal stem cells (MSCs) for the prevention of bronchopulmonary dysplasia (BPD) in preterm infants who have been treated with supplemental oxygen and mechanical ventilation.
Latest Advance
Study
  • Condition: Prevention of Bronchopulmonary Dysplasia (BPD) in Prematurity
  • Journal: Neonatal network : NN
  • Treatment Used: Pharmacotherapy
  • Number of Patients: 0
  • Published —
This article discusses pharmocotherapy for the prevention of bronchopulmonary dysplasia (BPD) in prematurity.
Latest Advance
Study
  • Condition: Neonates with ventilator-associated pneumonia
  • Journal: Pediatric pulmonology
  • Treatment Used: Respiratory treatment
  • Number of Patients: 199
  • Published —
The study researched the long-term and short-term effects of respiratory treatment for neonates with ventilator-associated pneumonia.
Latest Advance
Study
  • Condition: Tracheostomy decannulation of children with bronchopulmonary dysplasia
  • Journal: Pediatric pulmonology
  • Treatment Used: Polysomnography
  • Number of Patients: 125
  • Published —
The study researched the effects of polysomnography (sleep study) for tracheostomy decannulation of children with bronchopulmonary dysplasia.
Latest Advance
Study
  • Condition: Retinopathy of Prematurity (ROP) in Mechanically Ventilated Preterm Infants
  • Journal: BMC pulmonary medicine
  • Treatment Used: Aerosol Therapy
  • Number of Patients: 205
  • Published —
This study explored the effects of inhalation therapy on retinopathy of prematurity (ROP) for mechanically ventilated preterm infants.
Latest Advance
Study
  • Condition: Preterm infants at risk for or having respiratory distress syndrome
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Inositol
  • Number of Patients: 1177
  • Published —
The objective of the study was to assess the effectiveness and safety of inositol in preterm infants with or without respiratory distress syndrome (RDS) in reducing adverse neonatal outcomes.